Christine Brütting

Dr. Christine Brütting

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2012 in Plant Biology
Verified
Journal Article
Closed access
PDF file
CBChristine Brütting
Christine Brütting
IHI. Hensen
I. Hensen
KWK. Wesche
K. Wesche

22 December 2011 in Biodiversity and Conservation
Verified
Journal Article
Closed access
PDF file
CBChristine Brütting
Christine Brütting
KWK. Wesche
K. Wesche
SMStefan Meyer
Stefan Meyer
IHI. Hensen
I. Hensen

15 January 2018 in Frontiers in Microbiology
Verified
Journal Article
Open access
YRYomara Y. Bustamante Rivera
Yomara Y. Bustamante Rivera
CBChristine Brütting
Christine Brütting
CSCaroline Schmidt
Caroline Schmidt
IVInes Volkmer
Ines Volkmer
MSMartin Sebastian Staege
Martin Sebastian Staege
Endogenous viral elements (EVE) seem to be present in all eukaryotic genomes. The composition of EVE varies between different species. The endogenous retrovirus 3 (ERV3) is one of these elements that is present only in humans and other Catarrhini. Conservation of ERV3 in most of the investigated Catarrhini and the expression pattern in normal tissues suggest a putative physiological role of ERV3. On the other hand, ERV3 has been implicated in the pathogenesis of auto-immunity and cancer. In the present review we summarize knowledge about this interesting EVE. We propose the model that expression of ERV3 (and probably other EVE loci) under pathological conditions might be part of a metazoan SOS response.

23 February 2017 in BioMed Research International
Verified
Journal Article
Open access
PDF file
CBChristine Brütting
Christine Brütting
AEAlexander Emmer
Alexander Emmer
MKMalte E. Kornhuber
Malte E. Kornhuber
MSMartin Sebastian Staege
Martin Sebastian Staege
At least 8% of the human genome is composed of endogenous retrovirus (ERV) sequences. ERVs play a role in placental morphogenesis and can sometimes protect the host against exogenous viruses. On the other hand, ERV reactivation has been found to be associated with different diseases, for example, multiple sclerosis (MS), schizophrenia, type 1 diabetes mellitus (T1D), or amyotrophic lateral sclerosis (ALS). Little is known about the cooccurrence of these diseases. If all these diseases are caused by ERV, antiretroviral therapy should perhaps also show some effects in the other diseases. Here, we summarize literature demonstrating that some ERV-associated diseases seem to appear together more often than expected, for example, MS and ALS, MS and T1D, MS and schizophrenia, or ALS and T1D. In contrast, some ERV-associated diseases seem to appear together less frequently than expected, for example, schizophrenia and T1D. Besides, some reports demonstrate amelioration of MS, ALS, or schizophrenia under antiretroviral therapy in human immunodeficiency virus-infected patients. If such results could be confirmed in larger studies, alternative therapy strategies for ERV-associated diseases like MS and schizophrenia might be possible.

13 August 2012 in Agriculture, Ecosystems & Environment
Verified
Journal Article
Closed access
CBChristine Brütting
Christine Brütting
SMStefan Meyer
Stefan Meyer
PKP. Kühne
P. Kühne
IHI. Hensen
I. Hensen
KWK. Wesche
K. Wesche

12 May 2016 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
CBChristine Brütting
Christine Brütting
AEAlexander Emmer
Alexander Emmer
MKMalte Kornhuber
Malte Kornhuber
MSMartin S. Staege
Martin S. Staege